1-(2-氨基苯基)-2,2,2-三氟乙烷酮 | 351002-89-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(2-氨基苯基)-2,2,2-三氟乙烷酮
• 英文名称: 1-(2-aminophenyl)-2,2,2-trifluoroethanone
• CAS: 351002-89-6
• 化学式: C₈H₆F₃NO
• mdl: MFCD09863840
• 分子量: 189.137
• InChiKey: ZJPHDPZUAINCNU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 海关编码：
  2922399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(2-Aminophenyl)-2,2,2-trifluoroethan-1-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(2-Aminophenyl)-2,2,2-trifluoroethan-1-one
CAS number: 351002-89-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6F3NO
Molecular weight: 189.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(2-氨基苯基)-2,2,2-三氟乙烷酮 在 四甲基胍 作用下， 以 neat (no solvent) 为溶剂， 反应 16.0h， 以86%的产率得到rac-(6S,12S)-6,12-bis(trifluoromethyl)-5,6,11,12-tetrahydro-6,12-epoxydibenzo[b,f ][1,5]diazocine
  参考文献：
  名称：

  刚性 V 型环氧二苯并 [ b , f ][1,5]重氮辛的碱催化无溶剂合成

  摘要：

  报道了一种合成具有 V 形分子结构的环氧二苯并 [ b , f ] [1,5]重氮辛的新方法。这种独特的方法基于前所未有的碱催化、无溶剂自缩合和氟化邻苯二甲酸的交叉缩合-氨基苯酮。通过 X 射线分析和手性光学方法独立地证实了新合成的重氮辛的结构。重氮辛支架的刚性允许将外消旋体分离成单个对映异构体，这些对映异构体在高达 140 °C 时具有热稳定性。此外，通过进行一系列典型的转化，包括过渡金属催化的反应，在不影响双半胺亚基的情况下进行，证明了重氮辛支架的惰性。

  DOI：

  10.1021/acs.joc.1c00884
• 作为产物：
  描述：

  1-(2-氯苯基)-2,2,2-三氟乙醇 在 potassium dichromate 、 sodium azide 、 硫酸 、 5%-palladium/activated carbon 、 氢气 作用下， 以 水 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 88.0h， 生成 1-(2-氨基苯基)-2,2,2-三氟乙烷酮
  参考文献：
  名称：

  3-氟甲基-2,1-苯并异恶唑的合成

  摘要：

  通过叠氮化钠与 1-(2-卤代苯基)-2,2,2-三氟乙酮或 1 -(2-卤代苯基)-2,2-二氟乙酮被开发出来。3-氟甲基-2,1-苯并异恶唑是邻氟乙酰苯胺的通用前体。

  DOI：

  10.1007/s11172-014-0733-1

文献信息

• [EN] ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES ASSOCIATED WITH P13K MODULATION<br/>[FR] INHIBITEURS CHROMÉNONE ALLOSTÉRIQUES DE LA PHOSPHOINOSITIDE 3-KINASE (PI3K) POUR LE TRAITEMENT DE MALADIES ASSOCIÉES À LA MODULATION DE PI3K
  申请人：PETRA PHARMA CORP

  公开号：WO2021202964A1

  公开（公告）日：2021-10-07

  The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I), or a prodrug, solvate, enantiomer, stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, W, X, Y, s, and Ring A are as described herein.

  该披露涉及到式(I)的化合物，作为磷脂酰肌醇3-激酶（PI3K）的变构色酮抑制剂，在与PI3K调节相关的疾病或紊乱的治疗中有用，式(I)，或其前药、溶剂化合物、对映体、立体异构体、互变异构体或其药学上可接受的盐，其中R1、R2、R3、R4、R5、R6、R7、R8、R9、W、X、Y、s和环A如本文所述。
• Indium-Catalyzed Annulation of o-Acylanilines with Alkoxyheteroarenes: Synthesis of Heteroaryl[b]quinolines and Subsequent Transformation to Cryptolepine Derivatives
  作者：Kyohei Yonekura、Mika Shinoda、Yuko Yonekura、Teruhisa Tsuchimoto

  DOI：10.3390/molecules23040838

  日期：——

  We disclose herein the first synthetic method that is capable of offering heteroaryl[b]quinolines (HA[b]Qs) with structural diversity, which include tricyclic and tetracyclic structures with (benzo)thienyl, (benzo)furanyl, and indolyl rings. The target HA[b]Q is addressed by the annulation of o-acylanilines and MeO-heteroarenes with the aid of an indium Lewis acid that effectively works to make two

  我们在此公开了第一种合成方法，该方法能够提供具有结构多样性的杂芳基[b]喹啉（HA [b] Qs），包括具有（苯并）噻吩基，（苯并）呋喃基和吲哚基环的三环和四环结构。通过邻-苯丙氨酸和MeO-杂芳烃的环化反应，借助铟路易斯酸解决了目标HA [b] Q的问题，该路易斯酸有效地完成了一批中两种不同类型的NC和CC键的制备。随后可以将此处制备的一系列吲哚并[3,2-b]喹啉转化为结构上前所未有的隐血藤碱衍生物。机理研究表明，NC键形成之后是CC键形成。因此，铟催化的环化反应开始于邻酰基丙氨酸的NH 2基团以SNAr方式亲核连接到杂芳基环的MeO连接的碳原子上，从而形成NC键。然后，所得的中间体通过基于杂芳基环的碳原子对羰基碳原子的亲核攻击而环化以形成CC键，从而在芳香化脱水后提供HA [b] Q。
• Pd-Catalyzed Cross-Coupling of Hindered, Electron-Deficient Anilines with Bulky (Hetero)aryl Halides Using Biaryl Phosphorinane Ligands
  作者：Alison M. Wilders、Jeremy Henle、Michael C. Haibach、Rafal Swiatowiec、Jeffrey Bien、Rodger F. Henry、Shardrack O. Asare、Amanda L. Wall、Shashank Shekhar

  DOI：10.1021/acscatal.0c04280

  日期：2020.12.18

  ligands for Pd-catalyzed coupling of hindered, electron-deficient anilines with hindered (hetero)aryl halides, a challenging class of C–N cross-coupling reaction with few precedents. Broad substrate scope and functional group tolerance were observed under the reaction conditions. Computational studies suggest that ligands containing phenyl substituents provide greater activity through more favorable

  由联芳基伯膦加成反式，反式衍生的联芳基膦烷配体-二亚苄基丙酮（AlisonPhos和AliPhos）形成受阻电子缺陷苯胺与受阻（杂）芳基卤化物的钯催化偶联的高活性配体，这是一类具有挑战性的C-N交叉偶联反应，几乎没有先例。在反应条件下观察到较宽的底物范围和官能团耐受性。计算研究表明，与烷基取代的膦亚胺相比，含苯基取代基的配体通过更有利的苯胺键合在催化循环中提供更大的活性。在1,1,1,1,3,3,3-六氟异丙醇（HFIP）中，通过将伯联芳基膦在1,1,1,3,3,3-六氟异丙醇（HFIP）中的磷-迈克尔加成反应，合成联芳基膦酸酯的一般和高产程序还描述了相对温和的条件（23–110°C）。
• [EN] ERBB/BTK INHIBITORS<br/>[FR] INHIBITEURS DE ERBB/BTK
  申请人：DIZAL JIANGSU PHARMACEUTICAL CO LTD

  公开号：WO2019149164A1

  公开（公告）日：2019-08-08

  Disclosed are compounds inhibiting ErbBs (e. g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat ErbBs (especially mutant forms of ErbBs) or BTK associated diseases, including cancer.

  揭示了抑制ErbBs（例如EGFR或Her 2），特别是ErbBs的突变形式，以及BTK的化合物，其药用盐、水合物、溶剂合物或立体异构体，以及包含这些化合物的药物组合物。该化合物和药物组合物可以有效治疗ErbBs（特别是ErbBs的突变形式）或与BTK相关的疾病，包括癌症。
• Trifluoromethyl-promoted homocamptothecins: Synthesis and biological activity
  作者：Lingjian Zhu、Zhenyuan Miao、Chunquan Sheng、Wei Guo、Jianzhong Yao、Wenfeng Liu、Xiaoying Che、Wenya Wang、Pengfei Cheng、Wannian Zhang

  DOI：10.1016/j.ejmech.2010.02.051

  日期：2010.7

  The homocamptothecin (hCPT) represents a new class of topoisomerase inhibitor which combines enhanced plasma stability and strong antitumor activity. Fluorine imparts desirable characteristics to drugs by modulating both the pharmacokinetics and pharmacodynamic properties of a drug. Therefore, in an attempt to improve the antitumor activity of homocamptothecins, seven new 7-trifluoromethylated homocamptothecin

  同型喜树碱（hCPT）代表一类新的拓扑异构酶抑制剂，它具有增强的血浆稳定性和强大的抗肿瘤活性。氟通过调节药物的药代动力学和药效学性质赋予药物所需的特性。因此，为了提高同型喜树碱的抗肿瘤活性，通过脯氨酸催化的弗里德兰德法制备了七个新的7-三氟甲基化的同型喜树碱衍生物。评价了在体内和体外对癌细胞系的抗肿瘤活性，以及拓扑异构酶I介导的化合物6c和8b的DNA切割的抑制特性。这些三氟甲基化的hCPT衍生物中的几种（例如6a，6b和6c）具有比拓扑替康（TPT）更高的体外抗肿瘤活性。特别地，化合物6c显示出与TPT相当的有效体内抗肿瘤活性。